Keyword search
Filter results by
Search HelpKeyword(s)
Subject
Year of publication
Survey or statistical program
Results
All (15)
All (15) (0 to 10 of 15 results)
- Stats in brief: 45-28-0001202100100018Description:
Colorectal cancer screening, along with other health care services, was suspended in Canada in the initial phase of the COVID-19 pandemic response. This pause was deemed necessary to allow health care facilities to establish appropriate infection-control measures to prevent COVID-19 outbreaks and to reserve health system capacity for COVID-19 patients. The current article projects the impact of a three-month suspension of screening for colorectal cancer using a fecal test for average-risk individuals, and compares strategies to minimize the harm from screening interruptions. The projections come from OncoSim, a cancer microsimulation model co-developed by Statistics Canada and the Canadian Partnership Against Cancer.
Release date: 2021-06-17 - 2. Recent trends in prostate cancer in Canada ArchivedArticles and reports: 82-003-X201900400002Description:
Prostate cancer is the most common type of cancer in Canadian men. This study reports on trends in prostate cancer incidence, mortality, and stage at diagnosis in Canada from 1992 to 2015. It builds on previous Statistics Canada work by providing an up-to-date and in-depth analysis of trends in prostate cancer incidence, mortality and stage at diagnosis over time and by age group, including the impact of the updated (2014) Canadian prostate cancer screening guidelines. Data are from Statistics Canada's Canadian Cancer Registry and the Canadian Vital Statistics - Death Database Statistics Canada.
Release date: 2019-04-17 - Stats in brief: 82-624-X201600114649Description:
Congenital anomalies, commonly referred to as birth defects, describe conditions that develop in the fetus at the time of conception or during pregnancy. This article presents data on trends in the average age at death, and death rates from five of the most common congenital anomalies: circulatory anomalies; Spina Bifida; and three chromosomal anomalies-Down syndrome, Edwards' syndrome and Patau's syndrome. Data from the 1974 to 2012 Canadian Vital Statistics-Deaths Database will be used to examine differences in the death rate due to congenital anomalies, among infants in Canada.
Release date: 2016-09-29 - Stats in brief: 82-624-X201600114637Description:
This article highlights work that is being done to create laboratory reference ranges for substances measured in blood that are specific for the Canadian population. Results for two laboratory tests are presented to illustrate how reference ranges are created and how age and/or sex can influence normal values in a healthy population. This article uses data from the Canadian Health Measures Survey (2007–2011).
Release date: 2016-06-27 - Articles and reports: 82-003-X201501214293Description:
The University of Wisconsin Cancer Intervention and Surveillance Modeling Network breast cancer microsimulation model was adapted to simulate breast cancer incidence and screening performance in Canada. The model considered effects of breast density on the sensitivity and specificity of screening. The model’s ability to predict age-specific incidence of breast cancer was assessed.
Release date: 2015-12-16 - Articles and reports: 82-003-X201501214294Description:
This analysis employs a validated microsimulation model of breast cancer, adapted to the Canadian context, to predict health outcomes associated with different digital mammography screening strategies (including No Screening) across different age ranges. The model estimates the benefits, harms, limitations, and use of resources for each strategy.
Release date: 2015-12-16 - Articles and reports: 82-003-X201501214295Description:
Using the Wisconsin Cancer Intervention and Surveillance Monitoring Network breast cancer simulation model adapted to the Canadian context, costs and quality-adjusted life years were evaluated for 11 mammography screening strategies that varied by start/stop age and screening frequency for the general population. Incremental cost-effectiveness ratios are presented, and sensitivity analyses are used to assess the robustness of model conclusions.
Release date: 2015-12-16 - Articles and reports: 82-003-X201500514169Description:
The Cancer Risk Management Model incorporates the risk of developing cancer, disease screening and clinical management with cost and labour data to assess health outcomes and economic impact. A screening module added to the lung cancer module enables a variety of scenarios to be evaluated for different target populations with varying rates of participation, compliance, and frequency of low-dose computed tomography screening.
Release date: 2015-05-20 - 9. Screening for Chronic Diseases Among Métis ArchivedStats in brief: 89-637-X2013001Geography: CanadaDescription:
This fact sheet explores self-reported use of preventive screening tests for diabetes, high blood pressure, and prostate, breast and cervical cancers, as reported in the 2006 Aboriginal Peoples Survey. It focuses on people aged 15 and over who self-identified as Métis. The reported use of screening tests by Métis people is compared with national guidelines. Consideration is given to those with and without a regular doctor and those living in different geographical regions. Non-Aboriginal data are provided for comparison purposes when similar questions were asked on the 2008 Canadian Community Health Survey.
Release date: 2013-03-27 - 10. An update on mammography use in Canada ArchivedArticles and reports: 82-003-X200900310873Geography: CanadaDescription:
This article updates mammography use by Canadian women aged 50 to 69, and reports trends from 1990 to 2008 among the provinces.
Release date: 2009-06-30
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (15)
Analysis (15) (0 to 10 of 15 results)
- Stats in brief: 45-28-0001202100100018Description:
Colorectal cancer screening, along with other health care services, was suspended in Canada in the initial phase of the COVID-19 pandemic response. This pause was deemed necessary to allow health care facilities to establish appropriate infection-control measures to prevent COVID-19 outbreaks and to reserve health system capacity for COVID-19 patients. The current article projects the impact of a three-month suspension of screening for colorectal cancer using a fecal test for average-risk individuals, and compares strategies to minimize the harm from screening interruptions. The projections come from OncoSim, a cancer microsimulation model co-developed by Statistics Canada and the Canadian Partnership Against Cancer.
Release date: 2021-06-17 - 2. Recent trends in prostate cancer in Canada ArchivedArticles and reports: 82-003-X201900400002Description:
Prostate cancer is the most common type of cancer in Canadian men. This study reports on trends in prostate cancer incidence, mortality, and stage at diagnosis in Canada from 1992 to 2015. It builds on previous Statistics Canada work by providing an up-to-date and in-depth analysis of trends in prostate cancer incidence, mortality and stage at diagnosis over time and by age group, including the impact of the updated (2014) Canadian prostate cancer screening guidelines. Data are from Statistics Canada's Canadian Cancer Registry and the Canadian Vital Statistics - Death Database Statistics Canada.
Release date: 2019-04-17 - Stats in brief: 82-624-X201600114649Description:
Congenital anomalies, commonly referred to as birth defects, describe conditions that develop in the fetus at the time of conception or during pregnancy. This article presents data on trends in the average age at death, and death rates from five of the most common congenital anomalies: circulatory anomalies; Spina Bifida; and three chromosomal anomalies-Down syndrome, Edwards' syndrome and Patau's syndrome. Data from the 1974 to 2012 Canadian Vital Statistics-Deaths Database will be used to examine differences in the death rate due to congenital anomalies, among infants in Canada.
Release date: 2016-09-29 - Stats in brief: 82-624-X201600114637Description:
This article highlights work that is being done to create laboratory reference ranges for substances measured in blood that are specific for the Canadian population. Results for two laboratory tests are presented to illustrate how reference ranges are created and how age and/or sex can influence normal values in a healthy population. This article uses data from the Canadian Health Measures Survey (2007–2011).
Release date: 2016-06-27 - Articles and reports: 82-003-X201501214293Description:
The University of Wisconsin Cancer Intervention and Surveillance Modeling Network breast cancer microsimulation model was adapted to simulate breast cancer incidence and screening performance in Canada. The model considered effects of breast density on the sensitivity and specificity of screening. The model’s ability to predict age-specific incidence of breast cancer was assessed.
Release date: 2015-12-16 - Articles and reports: 82-003-X201501214294Description:
This analysis employs a validated microsimulation model of breast cancer, adapted to the Canadian context, to predict health outcomes associated with different digital mammography screening strategies (including No Screening) across different age ranges. The model estimates the benefits, harms, limitations, and use of resources for each strategy.
Release date: 2015-12-16 - Articles and reports: 82-003-X201501214295Description:
Using the Wisconsin Cancer Intervention and Surveillance Monitoring Network breast cancer simulation model adapted to the Canadian context, costs and quality-adjusted life years were evaluated for 11 mammography screening strategies that varied by start/stop age and screening frequency for the general population. Incremental cost-effectiveness ratios are presented, and sensitivity analyses are used to assess the robustness of model conclusions.
Release date: 2015-12-16 - Articles and reports: 82-003-X201500514169Description:
The Cancer Risk Management Model incorporates the risk of developing cancer, disease screening and clinical management with cost and labour data to assess health outcomes and economic impact. A screening module added to the lung cancer module enables a variety of scenarios to be evaluated for different target populations with varying rates of participation, compliance, and frequency of low-dose computed tomography screening.
Release date: 2015-05-20 - 9. Screening for Chronic Diseases Among Métis ArchivedStats in brief: 89-637-X2013001Geography: CanadaDescription:
This fact sheet explores self-reported use of preventive screening tests for diabetes, high blood pressure, and prostate, breast and cervical cancers, as reported in the 2006 Aboriginal Peoples Survey. It focuses on people aged 15 and over who self-identified as Métis. The reported use of screening tests by Métis people is compared with national guidelines. Consideration is given to those with and without a regular doctor and those living in different geographical regions. Non-Aboriginal data are provided for comparison purposes when similar questions were asked on the 2008 Canadian Community Health Survey.
Release date: 2013-03-27 - 10. An update on mammography use in Canada ArchivedArticles and reports: 82-003-X200900310873Geography: CanadaDescription:
This article updates mammography use by Canadian women aged 50 to 69, and reports trends from 1990 to 2008 among the provinces.
Release date: 2009-06-30
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: